SBI Securities’s Cardiff Oncology CRDF Stock Holding History

SBI Securities’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189	Buy	145 +1	+0.7%	+$2	﹤0.01%	3347
2026 Q1	$233	Hold	144	–	–	﹤0.01%	3166
2025 Q4	$405	Sell	144 -1	-0.7%	-$2	﹤0.01%	2949
2025 Q3	$299	Sell	145 -819	-85%	-$2.26K	﹤0.01%	3190
2025 Q2	$3.04K	Buy	964 +230	+31%	+$702	﹤0.01%	2217
2025 Q1	$2.31K	Buy	734 +79	+12%	+$312	﹤0.01%	2229
2024 Q4	$2.84K	Buy	+655	New	+$2.05K	﹤0.01%	2150

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SBI Securities's CRDF Position: Q2 2026 in Review

SBI Securities increased its Cardiff Oncology (CRDF) stake by 0.69% in Q2 2026, buying an estimated $2 and bringing the position to 145 shares worth $189. The position accounts for ﹤0.01% of the portfolio, ranked #3347.

SBI Securities first reported a position in CRDF in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.04K in Q2 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

SBI Securities held 145 shares of Cardiff Oncology worth $189 as of Q2 2026.
SBI Securities bought 1 Cardiff Oncology share in Q2 2026, an estimated $2.
Cardiff Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3347 holding.
SBI Securities first reported a position in Cardiff Oncology in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Cardiff Oncology position peaked at $3.04K in Q2 2025.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.